Industry news

• Optimizing Patient Support Through Effective Information Governance: Balancing Risks and Rewards

  26 September 2024 FiercePharma

  Patient support services have emerged as critical components to commercial success. When constructed correctly, they help you create more positive patient experiences and improve patient care and outcomes. Over the long term, patient support program (PSP) data also has the potential to serve as a rich source of real-world evidence for patient population research. 

• The government has expanded the list of specialized nutrition for disabled children

  25 September 2024 GxP news

  The list of specialized therapeutic nutrition products for disabled children has been expanded with three new items. The Russian government has approved the dry mixture “Alfare Gastro with breast milk oligosaccharides” and the “Frebini Energy Drink” for tube feeding in children with cystic fibrosis, alongside “Bifenilan” for dietary therapeutic nutrition aimed at patients suffering from phenylketonuria.

• New collaboration to boost access to innovative microbiome therapies

  25 September 2024 Catherine Eckford / European Pharmaceutical Review

  The new agreement, focused on improving regulation and drug development within the microbiome therapeutic sector, will harness cross-sector cooperation to ensure these medicines become available to more patients.

• Moscow Institute of Physics and Technology presents new method for determining cardiotoxicity of drugs

  24 September 2024 GxP news

  Researchers at the Moscow Institute of Physics and Technology (MIPT) Laboratory of Experimental and Cellular Medicine have created a groundbreaking method for detecting potentially cardio toxic substances during the preclinical phase, known as i-CARDIO. The danger of drugs for the heart is checked in four stages.

• Eurasian Economic Commission announced the 3rd draft amendment for veterinary drug rules

  24 September 2024 GxP news

  The Department for Sanitary, Phytosanitary, and Veterinary Measures of the Eurasian Economic Commission (EEC) recently convened a round table discussion focused on the implementation of regulations governing the circulation of veterinary medicines within the EAEU territory. During the event, commission representatives declared the commencement of the third draft of amendments to the EAEU regulations, which could potentially incorporate an extension of the transition periods.

• Construction of the oncology center in Perm will be completed in 2026

  23 September 2024 GxP news

  The construction of an oncology center in the Perm Region is ongoing, despite attempts by the regional prosecutor’s office to halt it in both 2022 and 2023. Dmitry Makhonin, the governor of the region, announced that the foundation is now complete, and the initial floors of both the central and ward blocks are currently being poured with concrete.

• The Cosmonaut Training Center will test the development of MioBody by Samara scientists

  23 September 2024 GxP news

  The National Technology Initiative Center at Samara State University has created innovative “smart clothing” designed to monitor muscle fatigue and atrophy during workouts, while also providing stimulation to help maintain muscle tone. The development was named MioBody and is currently undergoing the testing procedure (testing effectiveness and approval).

• Construction of the oncology center in Perm will be completed in 2026

  20 September 2024 GxP news

  The construction of an oncology center in the Perm Region is ongoing, despite attempts by the regional prosecutor’s office to halt it in both 2022 and 2023. Dmitry Makhonin, the governor of the region, announced that the foundation is now complete, and the initial floors of both the central and ward blocks are currently being poured with concrete.

• Moscow Institute of Physics and Technology presents new method for determining cardiotoxicity of drugs

  20 September 2024 GxP news

  Researchers at the Moscow Institute of Physics and Technology (MIPT) Laboratory of Experimental and Cellular Medicine have created a groundbreaking method for detecting potentially cardio toxic substances during the preclinical phase, known as i-CARDIO. The danger of drugs for the heart is checked in four stages.

• Within the next two years, every child in Russia battling hepatitis C can to be cured

  19 September 2024 GxP news

  Vladimir Chulanov, the chief freelance specialist in infectious diseases at the Russian Ministry of Health, announced that every child in the Russian Federation diagnosed with hepatitis C has the potential to be completely cured within the next two years. He noted that this opportunity will appear thanks to the Circle of Kindness foundation.